Charles Sternberg, Associate Editor08.30.23
Marrow Access Technologies has signed a distribution agreement with Spartan Medical, which will provide patients in the Department of Veterans Affairs (VA) and Department of Defense (DoD) access to the SmartShot Marrow Access Device, a novel solution for using the body's own stem cells and healing capabilities to treat orthopedic soft tissue injuries of the knee, hip, shoulder, foot, and ankle.
Marrow Access Technologies has taken a significant commercial step forward by partnering with Spartan Medical, a service-disabled veteran-owned business, to access the extensive federal marketplace of the Veterans Health Administration.
"We're proud to give our veterans and wounded warriors access to the newest standard of care for marrow stimulation therapy, and our partnership with veteran-owned Spartan Medical will enable healing and recovery for thousands," said Joseph Saladino, CEO and Co-founder of Marrow Access Technologies.
SmartShot is commercially available in the United States with rapidly expanding distribution.
Marrow Access Technologies has taken a significant commercial step forward by partnering with Spartan Medical, a service-disabled veteran-owned business, to access the extensive federal marketplace of the Veterans Health Administration.
About the SmartShot Marrow Access Device
SmartShot uses a patented mechanism to create deep, microneedle channels into the bone to stimulate the patient's healing reaction. The penetration of the outer layers of bone allows blood and stem cells from within the bone marrow to activate cartilage, ligament, bone and tendon healing. In a recently published independently funded and peer-reviewed animal study, researchers at the University of Pennsylvania concluded that SmartShot best preserved the underlying subchondral bone compared to traditional marrow access approaches."We're proud to give our veterans and wounded warriors access to the newest standard of care for marrow stimulation therapy, and our partnership with veteran-owned Spartan Medical will enable healing and recovery for thousands," said Joseph Saladino, CEO and Co-founder of Marrow Access Technologies.
SmartShot is commercially available in the United States with rapidly expanding distribution.